BRPI1008422A2 - composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico - Google Patents
composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórficoInfo
- Publication number
- BRPI1008422A2 BRPI1008422A2 BRPI1008422A BRPI1008422A BRPI1008422A2 BR PI1008422 A2 BRPI1008422 A2 BR PI1008422A2 BR PI1008422 A BRPI1008422 A BR PI1008422A BR PI1008422 A BRPI1008422 A BR PI1008422A BR PI1008422 A2 BRPI1008422 A2 BR PI1008422A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- solid pharmaceutical
- preparing
- polymorphic compound
- polymorphic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 239000007787 solid Substances 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900655A FR2942225B1 (fr) | 2009-02-13 | 2009-02-13 | Variete i du 6-oxo-6,7,8,9,10,11-hexahydroclyclohepta5°c!chromen-3 yl sulfamate de granulometrie reduite |
| FR0900656A FR2942226B1 (fr) | 2009-02-13 | 2009-02-13 | Nouveau polymorphe cristallin du 6-oxo+6,7,8,9,10,11-hexahydrocyclohepta°c!chromen-3-yl sulfamate |
| PCT/FR2010/000117 WO2010092260A2 (fr) | 2009-02-13 | 2010-02-12 | Compositions pharmaceutiques du 6-oxo-6.7.8,9.10.11-hexahydrocyclohepta mchromen-3-yl sulfamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008422A2 true BRPI1008422A2 (pt) | 2016-03-01 |
Family
ID=42562120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008422A BRPI1008422A2 (pt) | 2009-02-13 | 2010-02-12 | composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2396311A2 (pt) |
| JP (1) | JP2012517988A (pt) |
| KR (1) | KR20110115607A (pt) |
| CN (1) | CN102317276A (pt) |
| AU (1) | AU2010212753A1 (pt) |
| BR (1) | BRPI1008422A2 (pt) |
| CA (1) | CA2751393A1 (pt) |
| MX (1) | MX2011008239A (pt) |
| RU (1) | RU2011137516A (pt) |
| WO (1) | WO2010092260A2 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020510027A (ja) * | 2017-03-08 | 2020-04-02 | アリアド ファーマシューティカルズ，インコーポレーテッド | ５−クロロ−ｎ４−［２−（ジメチルホスホリル）フェニル］−ｎ２−｛２−メトキシ−４−［４−（４−メチルピペラジン−１−イル）ピペリジン−１−イル］フェニル｝ピリミジン−２，４−ジアミンを含む医薬製剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9603325D0 (en) * | 1996-02-16 | 1996-04-17 | Imperial College | A compound |
| US6921776B1 (en) * | 1996-02-16 | 2005-07-26 | Sterix Limited | Compound |
| CN1309387C (zh) * | 2003-04-15 | 2007-04-11 | 南昌弘益科技有限公司 | 溶出度得到提高的甲芬那酸分散片及其制备方法—镇痛、解热、抗炎药 |
| GB0408308D0 (en) * | 2004-04-14 | 2004-05-19 | Vectura Ltd | Pharmaceutical compositions |
| GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
| WO2008066899A2 (en) * | 2006-11-28 | 2008-06-05 | Marinus Pharmaceuticals | Nanoparticulate formulations and methods for the making and use thereof |
-
2010
- 2010-02-12 BR BRPI1008422A patent/BRPI1008422A2/pt not_active IP Right Cessation
- 2010-02-12 CA CA2751393A patent/CA2751393A1/fr not_active Abandoned
- 2010-02-12 EP EP10707096A patent/EP2396311A2/fr not_active Withdrawn
- 2010-02-12 MX MX2011008239A patent/MX2011008239A/es not_active Application Discontinuation
- 2010-02-12 RU RU2011137516/04A patent/RU2011137516A/ru not_active Application Discontinuation
- 2010-02-12 KR KR1020117021103A patent/KR20110115607A/ko not_active Withdrawn
- 2010-02-12 JP JP2011549626A patent/JP2012517988A/ja active Pending
- 2010-02-12 CN CN2010800077893A patent/CN102317276A/zh active Pending
- 2010-02-12 AU AU2010212753A patent/AU2010212753A1/en not_active Abandoned
- 2010-02-12 WO PCT/FR2010/000117 patent/WO2010092260A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2751393A1 (fr) | 2010-08-19 |
| KR20110115607A (ko) | 2011-10-21 |
| JP2012517988A (ja) | 2012-08-09 |
| WO2010092260A2 (fr) | 2010-08-19 |
| EP2396311A2 (fr) | 2011-12-21 |
| RU2011137516A (ru) | 2013-03-20 |
| WO2010092260A3 (fr) | 2011-02-17 |
| AU2010212753A1 (en) | 2011-09-01 |
| MX2011008239A (es) | 2011-09-06 |
| CN102317276A (zh) | 2012-01-11 |
| WO2010092260A8 (fr) | 2011-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0905717A2 (pt) | Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica | |
| BRPI1007161A2 (pt) | composição farmacêutica oral, e processo para preparar uma composição | |
| BRPI0909691A2 (pt) | Composto, método para preparar um composto, e, composição farmacêutica | |
| PT2121578T (pt) | Processo de preparação de ácido 5-bifenil-4-amino-2-metil-pentanoico | |
| BRPI0911254A2 (pt) | processo para a preparação de um composto | |
| BRPI0916712A2 (pt) | processo para preparar uma composição detergente | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BR112012016912A2 (pt) | composição de gel de diagnóstico, método para preparar uma composição de gel de diagnóstico | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BRPI0922566A2 (pt) | polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença. | |
| BRPI1012018A2 (pt) | processo para preparar um composto | |
| BRPI0910545A2 (pt) | processo contínuo para fazer composições farmacêuticas | |
| BRPI0914674A2 (pt) | processo para preparação de um pó | |
| PL2311970T3 (pl) | Sposób wytwarzania bioproduktów | |
| BRPI1011888A2 (pt) | processo para preparar um composto, e, composição. | |
| BRPI0820644A2 (pt) | método de preparação de uma composição, e, composição | |
| BRPI1007654A2 (pt) | composto, processo para a obtenção de um composto de fórmula geral e composição farmacêutica | |
| BRPI0921420A2 (pt) | processo para preparar compostos | |
| BR112012000258A2 (pt) | processo para preparar uma alquenona. | |
| BRPI1016109A2 (pt) | "composto, composição farmacêutica, e, processo para preparar um composto" | |
| IL206266A0 (en) | Process for recovering florfenicol from pharmaceutical compositions | |
| BRPI0911992A2 (pt) | processo para preparação de bifenilanilidas substituídas | |
| BRPI0811548A2 (pt) | Forma polimórfica de um composto, composição farmacêutica, e, processo para sintetizar uma forma polimórfica de um composto | |
| BR112013005986A2 (pt) | processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo | |
| BR112012002130A2 (pt) | processo para a preparação de composto,e, composto intermediário |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |